ETC
AMRX icon

Exchange Traded Concepts’s Amneal Pharmaceuticals AMRX Stock Holding History

Exchange Traded Concepts’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.34M Buy
366,090
+360,106
+6,018% +$4.93M 0.03% 439
2026
Q1 		$74.4K Buy
5,984
+2,765
+86% +$37.1K ﹤0.01% 1408
2025
Q4 		$40.6K Buy
3,219
+117
+4% +$1.34K ﹤0.01% 1461
2025
Q3 		$31.1K Buy
+3,102
New +$27.8K ﹤0.01% 1309

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Exchange Traded Concepts's AMRX Position: Q2 2026 in Review

Exchange Traded Concepts increased its Amneal Pharmaceuticals (AMRX) stake by 6,018% in Q2 2026, buying an estimated $4.93M and bringing the position to 366,090 shares worth $6.34M. The position accounts for 0.03% of the portfolio, ranked #439.

Exchange Traded Concepts first reported a position in AMRX in Q3 2025 and has held it in 4 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Exchange Traded Concepts held 366,090 shares of Amneal Pharmaceuticals worth $6.34M as of Q2 2026.
  • Exchange Traded Concepts bought 360,106 Amneal Pharmaceuticals shares in Q2 2026, an estimated $4.93M.
  • Amneal Pharmaceuticals made up 0.03% of Exchange Traded Concepts's portfolio in Q2 2026, its #439 holding.
  • Exchange Traded Concepts first reported a position in Amneal Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Exchange Traded Concepts's 13F filing for Q2 2026, filed 22 Jul 2026.